Loading…
ABS Distribution Inc. was warned for distributing electronic nicotine delivery system (ENDS) products without required premarket authorization as mandated under the Federal Food, Drug, and Cosmetic Act. The FDA determined the company was offering tobacco products for commercial distribution in the United States without compliance with FDA jurisdiction requirements, including the expanded definition of tobacco products that covers nicotine from any source following legislation signed in March 2022. The company failed to obtain premarket authorization orders for "new tobacco products" as required by law before legally marketing such products in the United States.